{"entity":{"type":"insider","cik":"0001619860","url":"/insider/0001619860","json_url":"/insider/0001619860.json","name":"Spectrum Pharmaceuticals Cayman, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":4,"first":"2016-03-11","last":"2017-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Spectrum Pharmaceuticals Cayman, L.P.","source":"filing","n_filings":4,"first_seen":"2016-03-11","last_seen":"2017-12-22"}],"transactions":[{"id":4874291,"accession":"0001209191-17-067043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-067043","line_url":"/filing/0001209191-17-067043","is_derivative":false,"issuer_cik":"0000831547","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000831547","owner_cik":null,"owner_name":"SPECTRUM PHARMACEUTICALS INC; Spectrum Pharmaceuticals Cayman, L.P.","owner_display_name":"SPECTRUM PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1519096.0,"shares_display":"1,519,096","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":15190.96,"total_display":"15,190.96","total_whole":"15,191","shares_owned_after":6897413.0,"shares_owned_after_display":"6,897,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-22","filed_date":"2017-12-22","scope":"insider","n_lines":2},{"id":2140959,"accession":"0001209191-16-147721","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-147721","line_url":"/filing/0001209191-16-147721","is_derivative":false,"issuer_cik":"0000831547","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000831547","owner_cik":null,"owner_name":"Spectrum Pharmaceuticals Cayman, L.P.; SPECTRUM PHARMACEUTICALS INC","owner_display_name":"Spectrum Pharmaceuticals Cayman, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1789062.0,"shares_display":"1,789,062","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":17890.62,"total_display":"17,890.62","total_whole":"17,891","shares_owned_after":5695242.0,"shares_owned_after_display":"5,695,242","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-28","filed_date":"2016-11-01","scope":"insider","n_lines":4},{"id":2516434,"accession":"0001209191-16-137368","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-137368","line_url":"/filing/0001209191-16-137368","is_derivative":false,"issuer_cik":"0000831547","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000831547","owner_cik":null,"owner_name":"Spectrum Pharmaceuticals Cayman, L.P.; SPECTRUM PHARMACEUTICALS INC","owner_display_name":"Spectrum Pharmaceuticals Cayman, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":164526.0,"shares_display":"164,526","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":1645.26,"total_display":"1,645.26","total_whole":"1,645","shares_owned_after":4921452.0,"shares_owned_after_display":"4,921,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-20","filed_date":"2016-08-16","scope":"insider","n_lines":2},{"id":2516430,"accession":"0001209191-16-137368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-137368","line_url":"/filing/0001209191-16-137368","is_derivative":false,"issuer_cik":"0000831547","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000831547","owner_cik":null,"owner_name":"Spectrum Pharmaceuticals Cayman, L.P.; SPECTRUM PHARMACEUTICALS INC","owner_display_name":"Spectrum Pharmaceuticals Cayman, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":980732.0,"shares_display":"980,732","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":9807.32,"total_display":"9,807.32","total_whole":"9,807","shares_owned_after":4823181.0,"shares_owned_after_display":"4,823,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-14","filed_date":"2016-08-16","scope":"insider","n_lines":2},{"id":2128401,"accession":"0001209191-16-107987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-107987","line_url":"/filing/0001209191-16-107987","is_derivative":false,"issuer_cik":"0000831547","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000831547","owner_cik":null,"owner_name":"Spectrum Pharmaceuticals Cayman, L.P.; SPECTRUM PHARMACEUTICALS INC","owner_display_name":"Spectrum Pharmaceuticals Cayman, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1688877.0,"shares_display":"1,688,877","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":16888.77,"total_display":"16,888.77","total_whole":"16,889","shares_owned_after":4237391.0,"shares_owned_after_display":"4,237,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-22","filed_date":"2016-03-11","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000895051","name":"CASI Pharmaceuticals, Inc.","url":"/issuer/0000895051","role":"Ten percent owner","n_filings":4,"first_seen":"2016-03-11","last_seen":"2017-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001619860","retrieved_at":"2026-08-25T22:16:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}